UB Paderborn / Katalog / Suche / in CDI

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

Cardiovascular diabetology, 2022-07, Vol.21 (1), p.1-129, Article 129

2022

Volltextzugriff (PDF)

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

Cardiovascular diabetology, 2021-02, Vol.20 (1), p.38-38, Article 38

2021

Volltextzugriff (PDF)

Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

Cardiovascular diabetology, 2018-01, Vol.17 (1), p.21-21, Article 21

2018

Volltextzugriff (PDF)

Oral glucose tolerance testing and cardiovascular disease

The lancet. Diabetes & endocrinology, 2016-09, Vol.4 (9), p.732-733

2016

Volltextzugriff (PDF)

Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients

Journal of the American College of Cardiology, 2015-10, Vol.66 (14), p.1634-1636

2015

Volltextzugriff (PDF)

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology

Diabetes care, 2017-09, Vol.40 (9), p.1233-1240

2017

Volltextzugriff (PDF)

Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management

Diabetes care, 2020-09, Vol.43 (9), p.2001-2009

2020

Volltextzugriff (PDF)

Glucose impairment despite normal HbA1c or fasting plasma glucose

Läkartidningen, 2015-09, Vol.112

Gyberg, Viveca

2015

Volltextzugriff (PDF)

Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population

Diabetes care, 2022-09, Vol.45 (9), p.2111-2117

2022

Volltextzugriff (PDF)

Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology

European heart journal, 2015-05, Vol.36 (19), p.1171-1177

2015

Volltextzugriff (PDF)

Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test

Diabetes research and clinical practice, 2022-01, Vol.183, p.109156, Article 109156

2022

Volltextzugriff (PDF)

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013

Global heart, 2017-12, Vol.12 (4), p.315-322.e3

2017

Volltextzugriff (PDF)

The Accuracy of Point-of-Care Equipment for Glucose Measurement in Screening for Dysglycemia in Patients with Coronary Artery Disease

Diabetes technology & therapeutics, 2018-09, Vol.20 (9), p.596

2018

Volltextzugriff (PDF)

Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry

Diabetes research and clinical practice, 2022-01, Vol.183, p.109156-109156

2022

Volltextzugriff (PDF)

Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje

European journal of preventive cardiology, 2018-12, Vol.25 (18), p.1990-1999

2018

Volltextzugriff (PDF)

ACHIEVEMENT OF LIFESTYLE, BLOOD PRESSURE, LIPIDS AND DIABETES GOALS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE ACROSS EUROPE: RESULTS OF EUROASPIRE IV SURVEY

Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1976-1976

2016

Volltextzugriff (PDF)

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV

Diabetes care, 2017-09, Vol.40 (9), p.1233-1240

2017

Volltextzugriff (PDF)

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA^sub 1c^ in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV

Diabetes care, 2017-09, Vol.40 (9), p.1233

2017

Volltextzugriff (PDF)

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey

International journal of cardiology, 2018-12, Vol.272, p.20-25

2018

Volltextzugriff (PDF)

Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction

Diabetes & vascular disease research, 2018-11, Vol.15 (6), p.511-518

2018

Volltextzugriff (PDF)

149 Lifestyle, Blood Pressure, Lipids and Diabetes Management in Patients with Coronary Heart Disease From 24 Countries in Europe

Heart (British Cardiac Society), 2015-06, Vol.101 (Suppl 4), p.A86-A86

2015

Volltextzugriff (PDF)

149Lifestyle, Blood Pressure, Lipids and Diabetes Management in Patients with Coronary Heart Disease From 24 Countries in Europe

Heart (British Cardiac Society), 2015-06, Vol.101 (Suppl 4), p.A86-A86

2015

Volltextzugriff (PDF)

Accuracy of a Simplified Glucose Measurement Device--The HemoCue Glucose 201RT

Diabetes technology & therapeutics, 2015-10, Vol.17 (10), p.755

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

Undetected dysglycaemia common in primary care patients treated for hypertension and/or dyslipidaemia: on the need for a screening strategy in clinical practice. A report from EUROASPIRE IV a registry from the EuroObservational Research Programme of the European Society of Cardiology

Oral glucose tolerance testing and cardiovascular disease

Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV: A Survey From the European Society of Cardiology

Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management

Glucose impairment despite normal HbA1c or fasting plasma glucose

Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population

Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions

Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV--a survey from the European Society of Cardiology

Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013

The Accuracy of Point-of-Care Equipment for Glucose Measurement in Screening for Dysglycemia in Patients with Coronary Artery Disease

Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry

Effectiveness of different outreach strategies to identify individuals at high risk of diabetes in a heterogeneous population: a study in the Swedish municipality of Södertälje

ACHIEVEMENT OF LIFESTYLE, BLOOD PRESSURE, LIPIDS AND DIABETES GOALS FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE ACROSS EUROPE: RESULTS OF EUROASPIRE IV SURVEY

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA1c in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV

The Prognostic Value of Fasting Plasma Glucose, Two-Hour Postload Glucose, and HbA^sub 1c^ in Patients With Coronary Artery Disease: A Report From EUROASPIRE IV

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey

Dynamics of testosterone levels in patients with newly detected glucose abnormalities and acute myocardial infarction

149 Lifestyle, Blood Pressure, Lipids and Diabetes Management in Patients with Coronary Heart Disease From 24 Countries in Europe

149Lifestyle, Blood Pressure, Lipids and Diabetes Management in Patients with Coronary Heart Disease From 24 Countries in Europe

Accuracy of a Simplified Glucose Measurement Device--The HemoCue Glucose 201RT

Suchergebnisse filtern